Show simple item record

dc.contributor.authorWu, T.
dc.contributor.authorWilliams, C.
dc.contributor.authorVranek, K.
dc.date.accessioned2019-03-29T14:42:01Z
dc.date.available2019-03-29T14:42:01Z
dc.date.issued2019
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85044587737&doi=10.1016%2fj.sapharm.2018.03.065&partnerID=40&md5=1097796b2e2e5c8971707e43f063168c
dc.identifier.urihttp://hdl.handle.net/10713/8583
dc.description.abstractThe 340B Drug Pricing Program was intended to stretch federal resources by providing significant discounts to covered entities providing care to underserved populations. Program implementation and evidence of expanding services to higher income patients has brought more scrutiny and calls for elimination of the program. While additional review and reform may be warranted, profitability from 340B discounts enables covered entities to provide additional services that may not be feasible in absence of the program. This case report demonstrates one institution's use of 340B discounts to financially justify providing bedside medication delivery services for patients at the time of discharge from an inpatient admission. A simple financial model was developed using hospital data and inputs from available literature to estimate gross profit and earnings before interest, taxes, depreciation, and amortization (EBITDA) with and without 340B discounts. Without the 340B drug price discounts, the service would operate at a financial loss, and further investigation must be done to determine whether other clinical or economic benefits would warrant discharge medication delivery at the institution. © 2018 The Authorsen_US
dc.description.urihttps://dx.doi.org/10.1016/j.sapharm.2018.03.065en_US
dc.language.isoen_USen_US
dc.publisherElsevier Inc.en_US
dc.relation.ispartofResearch in Social and Administrative Pharmacy
dc.subject340Ben_US
dc.subjectdrug pricingen_US
dc.subjecttransitions of careen_US
dc.subject.meshHealth Services Researchen_US
dc.titleUsing 340B drug discounts to provide a financially sustainable medication discharge serviceen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.sapharm.2018.03.065
dc.identifier.pmid29606609


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record